Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT06440356
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with idiopathic trigeminal neuralgia as defined by the International Headache Society (2).
* Patients diagnosed with idiopathic trigeminal neuralgia and receiving medical treatment (carbamazepine, etc.)
* Patients with unilateral, severe, sudden onset of facial pain along the branches of the trigeminal nerve.
* Patients who have not previously received any interventional treatment for TN.
* Patients recently diagnosed and started on a first dose of carbamazepine and its derivatives
Exclusion Criteria:
* • Patients diagnosed with type 2 (atypical, symptomatic) trigeminal neuralgia as defined by the International Headache Society (2).
* Patients with etiologies such as tumour, multiple sclerosis or neurovascular compression on radiography.
* Pregnant women
* Patients with systemic diseases such as diabetes, cardiovascular disease, hypertension, etc.
* Patients who have been previously diagnosed and treated with any type of TN therapy.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06440356
Study Brief:
Protocol Section:
NCT06440356